Ronit Goldberg

Dr. Ronit Goldberg


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2020 in Science
Verified
Journal Article
Closed access
WLWeifeng Lin
Weifeng Lin
MKMonika Kluzek
Monika Kluzek
NINoa Iuster
Noa Iuster
ESEyal Shimoni
Eyal Shimoni
NKNir Kampf
Nir Kampf
JKJacob Klein
Jacob Klein
Slippery surfaces using lipids: In engineered systems, a reduction in friction can come from the use of lubricants or through surface coatings that are inherently slippery. For most hydrogels, which are cross-linked polymers heavily swelled with water, surface lubrication typically comes from trapped liquids that help to form a slippery surface. Drawing inspiration from articular cartilage that in part uses a lipid boundary layer, Lin et al. designed hydrogels with small concentrations of lipids that are continuously exuded toward the surface to make a slippery layer (see the Perspective by Schmidt). Friction and wear of the hydrogels was reduced by up to a factor of 100, and the effect was observed even after the hydrogels were dried and rehydrated. Science , this issue p. 335 ; see also p. 288

18 November 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SSShai Shemesh
Shai Shemesh
ODOleg Dolkart
Oleg Dolkart
RGRonit Goldberg
Ronit Goldberg
SJSabrina Jahn
Sabrina Jahn
AKAmal Khoury
Amal Khoury
MDMichael Drexler
Michael Drexler
Background/Objectives: Osteoarthritis (OA) is a common disease that affects almost half the population at some point in their lives, causing pain and decreased functional capacity. New conservative treatment modalities are being proposed to provide symptomatic relief and delay surgical intervention. This study aimed at evaluating the safety of the novel liposomal boundary lubricant, injected intra-articularly in patients with moderate knee OA. Additionally, the effect on the functionality and life quality was assessed. Methods: Eighteen of the twenty screened subjects met inclusion criteria and were enrolled in the study. After receiving a single IA injection of AqueousJoint, patients were prospectively evaluated at baseline and at 2, 4, 8, 12, and 26 weeks. Numeric Pain Rating Scale (NRS), Knee injury and Osteoarthritis Outcome Score (KOOS), Short Form Health Survey (SF12) and range of motion were also recorded. Results: The final analysis was conducted on 18 subjects. No adverse events related to the investigational product were observed in the study. No serious adverse events were observed at all. A significant decrease in pain was demonstrated at all time points vs. baseline (Friedman X2 = 35.08, p < 0.001). Significant improvement was demonstrated in KOOS pain, symptoms, sports, and ADL subscales (p < 0.001). Conclusions: Despite a relatively small sample, it was demonstrated that single IA AqueousJoint injection is a safe procedure, resulting in significant pain reduction, higher ADL score, and higher KOOS sport scores. The effects lasted up to 6 months.